Search Results 1091-1100 of 13934 for Assay
Laboratory-confirmed SARS-CoV-2 infection as determined by a RT-PCR result from any specimen (or other commercial or public health assay) ≤ 72 hours from ...
GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...
I think the prudent thing to do would be to contact your physician and determine what assays they have available. Related posts: "Mayo Clinic Laboratories ...
... assays for detection of hepatocellular carcinoma (HCC). A Study Of LOXO-292 In Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, And ...
Positive or indeterminate Interferon Gamma Release Assay (IGRA) test results or results from another positive TB test at screening based on acceptable local ...
Fiesel's team use genetic models to advance the mechanistic understanding of this pathway. The team develops biomarker assays and small molecule compounds. This ...
Fecal calprotectin assay performs well as biomarker for measurement of ulcerative colitis disease activity. FC levels can accurately identify endoscopic and ...
While assays exist to detect and identify the presence of microbes, the tests can be negative, making it challenging to determine if a patient has an infection.
... assay for at least 12 months from the first documentation of the MMR;; Has been in MMR (i.e. MR3) but still has detectable BCR/ABL transcript by a standard ...
Known tumor/immune cell PD-L1 status by any assay. Adequate organ function including: Cardiac ejection fraction at or above the institutional lower limit of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.